Using future thinking to help smokers reduce cigarette use
Pilot Study of Episodic Future Thinking Among Cigarette Smokers
NA · Roswell Park Cancer Institute · NCT05825001
This study tests if thinking about positive future experiences can help smokers cut down on their cigarette use.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 96 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Roswell Park Cancer Institute (other) |
| Locations | 1 site (Buffalo, New York) |
| Trial ID | NCT05825001 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the effectiveness of an innovative approach called episodic future thinking (EFT) to help reduce cigarette consumption among smokers. Participants are randomly assigned to either an active group that engages with positive future events or a control group that reflects on positive past events. Both groups will use a carbon monoxide monitor to track their smoking behavior throughout the study. The aim is to determine if anticipating positive future experiences can motivate smokers to cut down on their cigarette use.
Who should consider this trial
Good fit: Ideal candidates for this study are daily smokers who consume at least 10 cigarettes, are willing to quit in the next 30 days, and have low socioeconomic status.
Not a fit: Patients who are currently using nicotine replacement therapy or other smoking cessation medications may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could provide a novel and effective method for helping smokers reduce their cigarette consumption and potentially quit smoking.
How similar studies have performed: While the approach of using episodic future thinking is innovative, similar studies have shown promise in behavioral interventions for smoking cessation, suggesting potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Smoke \>= 10 cigarettes daily * \>32 on the Vividness of Visual Imagery Questionnaire (VVIQ) * No regular use of other tobacco products * In possession of a smartphone with text messaging capabilities * Willing to quit smoking in the next 30 days * Low socioeconomic status * Veteran of the US armed services Exclusion Criteria: * Unable or unwilling to provide verbal consent * Unable or unwilling to provide data to the research team * Current use of nicotine replacement therapy, bupropion, or varenicline * Use of drugs of abuse in the past 30 days * Living in the same household as a participant already enrolled in this study * Unable or unwilling to use nicotine patches
Where this trial is running
Buffalo, New York
- Roswell Park Comprehensive Cancer Center — Buffalo, New York, United States (RECRUITING)
Study contacts
- Principal investigator: Christine Sheffer — Roswell Park
- Study coordinator: Christine Sheffer
- Email: Christine.Sheffer@roswellpark.org
- Phone: 716-845-1186
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Cigarette Smoking-Related Carcinoma